Hosted on MSN2mon
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...
GlobalData on MSN3d
New CEOs to join Merck KGaA’s executive board
Jean-Charles Wirth and Danny Bar-Zohar are set to assume the life science and healthcare CEO roles respectively.